Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023

Rhea-AI Summary

Orthofix Medical Inc. (NASDAQ:OFIX) announced it will release its fourth quarter 2022 financial results for both Orthofix and SeaSpine, following their merger on January 5, 2023. The results will be disclosed on March 6, 2023, after market close, with a conference call scheduled at 4:30 p.m. ET the same day. The newly merged company positions itself as a leader in spine and orthopedics, distributing products across approximately 68 countries. The combined entity offers a comprehensive portfolio that includes biologics, spinal hardware, and surgical navigation systems, supported by its extensive global operations.

Positive

• Merged entity enhances market position in spine and orthopedics.
• Wide distribution network in approximately 68 countries.

Negative

• None.

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter 2022 financial results of stand-alone Orthofix as well as stand-alone SeaSpine, which was merged into Orthofix effective January 5, 2023, on Monday, March 6, 2023 after market close. The company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.

Interested parties may access the conference call by dialing (888) 330-2508 in the U.S., and (240) 789-2735 in all other locations, and referencing the event passcode 9556380. A replay of the call will be available for three weeks by dialing (800) 770-2030 in the U.S., and (647) 362-9199 in all other locations, and entering the event passcode 9556380. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.

About the Combined Company:

The newly merged Orthofix-SeaSpine organization is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.

The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005297/en/

Alexa Huerta

Investor Relations

Tel 214 937 3190

alexahuerta@orthofix.com

Denise Landry

Media Relations

Tel 214 937 2529

deniselandry@orthofix.com

Source: Orthofix Medical Inc.

FAQ

What will Orthofix release on March 6, 2023?

Orthofix will release its fourth quarter 2022 financial results for both Orthofix and SeaSpine.

What is the significance of the merger between Orthofix and SeaSpine?

The merger enhances Orthofix's position as a leading global spine and orthopedics company.

How can I access the Orthofix conference call on March 6, 2023?

Dial (888) 330-2508 in the U.S. or (240) 789-2735 internationally, using passcode 9556380.

What are Orthofix’s main products after the merger?

Orthofix offers biologics, spinal hardware, bone growth therapies, and a surgical navigation system.